In addition, the administration of caffeine in mice resulted in decreased or increased levels of certain proteins, such as Insig2, Rbp4, and Igfbp1, which have been associated with improved obesity, type 2 diabetes mellitus (T2DM), and cardiovascular pathologies. Here, IGFBP1 is linked to type 2 diabetes mellitus.